1332 related articles for article (PubMed ID: 20737451)
1. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Yu J; Shixia CZ; Wu Y; Duan T
Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
[TBL] [Abstract][Full Text] [Related]
2. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
[TBL] [Abstract][Full Text] [Related]
3. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
5. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.
Florio P; Reis FM; Pezzani I; Luisi S; Severi FM; Petraglia F
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):165-9. PubMed ID: 12601840
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia.
Spencer K; Cowans NJ; Chefetz I; Tal J; Kuhnreich I; Meiri H
Prenat Diagn; 2007 Mar; 27(3):258-63. PubMed ID: 17278173
[TBL] [Abstract][Full Text] [Related]
7. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
[TBL] [Abstract][Full Text] [Related]
9. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
[TBL] [Abstract][Full Text] [Related]
10. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler.
Aquilina J; Thompson O; Thilaganathan B; Harrington K
Ultrasound Obstet Gynecol; 2001 Jun; 17(6):477-84. PubMed ID: 11422967
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
12. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
13. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry.
Madazli R; Kuseyrioglu B; Uzun H; Uludag S; Ocak V
Int J Gynaecol Obstet; 2005 Jun; 89(3):251-7. PubMed ID: 15919391
[TBL] [Abstract][Full Text] [Related]
14. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk.
Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
Ultrasound Obstet Gynecol; 2010 Jun; 35(6):671-9. PubMed ID: 20069559
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia.
Li L; Zheng Y; Zhu Y; Li J
Exp Ther Med; 2016 Oct; 12(4):2515-2520. PubMed ID: 27698752
[TBL] [Abstract][Full Text] [Related]
17. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
[TBL] [Abstract][Full Text] [Related]
18. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
[TBL] [Abstract][Full Text] [Related]
19. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women.
Keikkala E; Forstén J; Ritvos O; Stenman UH; Kajantie E; Hämäläinen E; Räikkönen K; Villa PM; Laivuori H
Pregnancy Hypertens; 2021 Aug; 25():116-122. PubMed ID: 34116346
[TBL] [Abstract][Full Text] [Related]
20. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
